Insight

Cross-border flows of biological samples used in a clinical trial do not require authorisation from the French Ministry of Research

Cross-border flows of biological samples used in a clinical trial do not require authorisation from the French Ministry of Research

Thomas Roche

Thomas Roche

March 5, 2020 03:18 AM

International multi-centre clinical trials very often require cross-border flows of biological samples. These flows are intended to transfer the samples to the central laboratories, which may not necessarily be in the same country as the investigating centres that collected the biological samples. In order to carry out such flows in the context of a clinical trial, it is not necessary for French or foreign sponsors to obtain an import and/or export authorisation issued by the French Ministry of Research. It is important to bear in mind that biological samples taken for the purposes of a clinical study protocol and used in this context are not subject to the legal provisions governing the preparation and storage of biological samples intended to be used for research purposes. This exemption regime is provided for in Articles L. 1243-3 and L. 1243-4 of the French Public Health Code. Consequently, the provisions of paragraphs 4 of sections I and II of Article L. 1245-5-1 of the French Public Health Code, which require the authorisation of the French Ministry of Research prior to the import and export of biological samples, should not be applied to these samples. The exemption for samples taken in application of a study protocol is explained by the nature of the activities carried out with these samples.The protocol of a clinical trial may provide that biological samples will be collected for the trial. These may include blood samples, biopsies, or other biological material samples or collections. The purposes of these samples may be varied, but their primary purpose is to determine the biological characteristics of an individual, to narrow or confirm a diagnosis, to assess metabolic function, toxicity or concentration of a tested product, etc. These biological samples enable medical biology examinations to be carried out in the specific context of a clinical trial. Samples taken in the context of a clinical trial (pre-analytical phase) are analysed by a laboratory (analytical phase) and then communicated to the investigator or sponsor for contextual interpretation (post-analytical phase) specific to the clinical trial.These three phases characterise the conduct of a medical biology examination as defined in Article L. 6211-2 of the French Public Health Code.In accordance with section 8.4.9 of the French version of the Good Clinical Practices (GCP) set by the decision of 24 November 2006, these analyses must be carried out in accordance with the guide for the proper performance of medical biology analyses as defined by the decree of 26 November 1999 relating to the proper performance of medical biology analyses (“l’arrêté du 26 novembre 1999 relatif à la bonne exécution des analyses de biologies médicales »).

The GCP provide in fact that the "Trial Master File" must contain a summary document for each person involved in the trial. If this document has been drafted by the biologist as advised by the decree of 26 November 1999 relating to the proper performance of medical biology analyses, it must indicate:

  • the different results with the date and time of sampling and the time of performance of the tests,
  • control sample results with the same time series information,
  • any comments and incidents that may have occurred.
n the case of clinical trials, it is often decided to entrust a so-called "central" medical biology analysis laboratory with carrying out the analytical phases imposed by a protocol. When there are several investigation sites, all the samples taken at these investigation sites (pre-analytical phase) which are spread over different health care institutions in different countries may be centralised at one or more medical biology analysis laboratories. As a consequence, when these central laboratories are located abroad, this implies cross-border flows of samples. These flows are covered by legal provisions which do not require prior authorisation. These provisions are covered by Article L. 1245-5-1 of the French Public Health Code (CSP) and in particular paragraphs 3 of I and II thereof, which concern flows within the EU or with EEA Member States and those outside the EU or EEA respectivelyFor example, paragraph 3 of section I of Article L. 1245-5-1 of the French Public Health Code (flows within the EU or with EEA Member States) provides as follows :"Only persons whose activity involves medical biology examinations, anatomical and topical pathology examinations, forensic expertise or quality control or evaluation, in particular of in vitro diagnostic medical devices, may obtain biological samples from a Member State of the European Union or a State party to the Agreement on the European Economic Area. Similarly, only these persons may provide these samples to an approved establishment in a Member State of the European Union or a State party to the Agreement on the European Economic Area.” Therefore, medical biology laboratories involved at the request of a sponsor in a clinical trial may import and export biological samples ("only persons whose [...] may") without specific authorisation. Paragraphs 3 of sections I and II of Article L. 1245-5-1 must therefore be analysed in comparison with paragraphs 4 of sections I and II, which require authorisation from the Minister responsible for research ("Only bodies authorised by the Minister responsible for research may") to obtain (import) or provide (export) biological samples for scientific purposes. Thus, it appears that cross-border flows of biological samples carried out within the framework of a clinical trial are not subject to prior authorisation by the Ministry of Research. Finally, it should be recalled that the flows of samples carried out for the purposes of a clinical trial are detailed in a study protocol, which is authorised by the competent authorities in the field of clinical research and in particular by the ANSM (French National Agency for the Safety of Medicines and Health Products).Is it really useful to increase the number of administrative authorisations to allow cross-border flows of biological samples which are necessary to conduct clinical trials ?

Trending Articles

Announcing the 2023 The Best Lawyers in America Honorees


by Best Lawyers

Only the top 5.3% of all practicing lawyers in the U.S. were selected by their peers for inclusion in the 29th edition of The Best Lawyers in America®.

Gold strings and dots connecting to form US map

Announcing the 2022 Best Lawyers® in the United States


by Best Lawyers

The results include an elite field of top lawyers listed in the 28th Edition of The Best Lawyers in America® and in the 2nd Edition of Best Lawyers: Ones to Watch in America for 2022.

2022 Best Lawyers Listings for United States

2021 Best Lawyers: The Global Issue


by Best Lawyers

The 2021 Global Issue features top legal talent from the most recent editions of Best Lawyers and Best Lawyers: Ones to Watch worldwide.

2021 Best Lawyers: The Global Issue

The U.S. Best Lawyers Voting Season Is Open


by Best Lawyers

The voting season for the 31st edition of The Best Lawyers in America® and the 5th edition of Best Lawyers: Ones to Watch® in America is officially underway, and we are offering some helpful advice to this year’s voters.

Golden figures of people standing on blue surface connected by white lines

How To Find A Pro Bono Lawyer


by Best Lawyers

Best Lawyers dives into the vital role pro bono lawyers play in ensuring access to justice for all and the transformative impact they have on communities.

Hands joined around a table with phone, paper, pen and glasses

The Best Lawyers in Australia™ 2024 Launch


by Best Lawyers

Best Lawyers is excited to announce The Best Lawyers in Australia™ for 2023, including the top lawyers and law firms from Australia.

Australian Parliament beside water at sunset

How Palworld Is Testing the Limits of Nintendo’s Legal Power


by Gregory Sirico

Many are calling the new game Palworld “Pokémon GO with guns,” noting the games striking similarities. Experts speculate how Nintendo could take legal action.

Animated figures with guns stand on top of creatures

What the Courts Say About Recording in the Classroom


by Christina Henagen Peer and Peter Zawadski

Students and parents are increasingly asking to use audio devices to record what's being said in the classroom. But is it legal? A recent ruling offer gives the answer to a question confusing parents and administrators alike.

Is It Legal for Students to Record Teachers?

Inflation Escalation


by Ashley S. Wagner

Inflation and rising costs are at the forefront of everyone’s mind as we enter 2023. The current volatile market makes it more important than ever to understand the rent escalation clauses in current and future commercial lease agreements.

Suited figure in front of rising market and inflated balloon

The Upcycle Conundrum


by Karen Kreider Gaunt

Laudable or litigious? What you need to know about potential copyright and trademark infringement when repurposing products.

Repurposed Products and Copyright Infringemen

8 Different Types of Criminal Defenses in Law


by Best Lawyers

Learn about the different types of criminal defenses available in law, including innocence, self-defense, insanity and more. Protect your rights today.

Silver handcuffs laying on finger printed papers

Best Lawyers: Ones to Watch in America for 2023


by Best Lawyers

The third edition of Best Lawyers: Ones to Watch in America™ highlights the legal talent of lawyers who have been in practice less than 10 years.

Three arrows made of lines and dots on blue background

A Celebration of Excellence: The Best Lawyers in Canada 2024 Awards


by Best Lawyers

As we embark on the 18th edition of The Best Lawyers in Canada™, we are excited to highlight excellence and top legal talent across the country.

Abstract image of red and white Canada flag in triangles

Wage and Overtime Laws for Truck Drivers


by Greg Mansell

For truck drivers nationwide, underpayment and overtime violations are just the beginning of a long list of problems. Below we explore the wages you are entitled to but may not be receiving.

Truck Driver Wage and Overtime Laws in the US

Choosing a Title Company: What a Seller Should Expect


by Roy D. Oppenheim

When it comes to choosing a title company, how much power exactly does a seller have?

Choosing the Title Company As Seller

The 2024 Best Lawyers in Spain™


by Best Lawyers

Best Lawyers is honored to announce the 16th edition of The Best Lawyers in Spain™ and the third edition of Best Lawyers: Ones to Watch in Spain™ for 2024.

Tall buildings and rushing traffic against clouds and sun in sky